Control Bionics (ASX: CBL) registers NeuroStrip with US FDA as commercial execution becomes the next test
Read More Pharma Industry News InventisBio licenses lung cancer drug D-0316 to Betta Pharma in RMB230m deal In a significant development within the pharmaceutical industry, Shanghai-based InventisBio has entered into a strategic partnership with Betta… bypharmanewsdailyDecember 31, 2018